What is BPC-157?

BPC-157 (Body Protection Compound 157, laboratory code PL 14736) is a synthetic peptide composed of 15 amino acids. It is known for its potential to protect organs under conditions of stress, injury, and inflammation. Peptides of this type are linked to the gastrointestinal tract’s natural defense mechanisms: in the presence of physiological stress, the stomach activates protective responses that help preserve tissue integrity.

---

What preclinical studies suggest

Most of the available evidence on BPC-157 comes from animal studies. In these models, the peptide has shown a protective effect that is not limited to the stomach and intestines but may extend to:

• support for treating gastric ulcers and protecting the mucosa

• recovery in cases of intestinal damage (including inflammatory conditions and fistulas in experimental models)
• support for the healing of bones, joints, tendons, and ligaments

• potential support in injuries to certain organs (e.g., pancreas and liver in animal models)

Research also indicates that BPC-157 may influence various growth factors involved in tissue repair and angiogenesis (the formation of new blood vessels), which is considered central to the regeneration process following an injury. For more information on the product, see TAD-600 – glutathione, an antioxidant peptide

---

Mechanism of action (summary)

Based on experimental data, BPC-157 appears to act through multiple mechanisms:

• nitric oxide (NO) pathway: contributes to the regulation of vascular function and local blood flow
• stimulation of repair mediators (including VEGF, TGF-β, FGF) associated with regeneration and angiogenesis

• activation of fibroblasts: cells essential for collagen production and connective tissue repair

• modulation of inflammation, with possible support for healing in various experimental conditions

---

Tendons, ligaments, and muscles

In animal models, BPC-157 has often been studied for the repair of tendons and ligaments, tissues known to heal slowly due to poor vascularization. Experimental observations include improvements in collagen structure and the mechanical strength of the tissue during the recovery phase.

Even at the level of skeletal muscle

---

Skin, Circulation, and the Nervous System (Experimental Field)

Some preclinical studies link BPC-157 to:

• support for the healing of skin lesions and experimental burns
• modulation of processes related to microcirculation and endothelial integrity
• possible neuroprotective effects in models of ischemia/stroke and neurological damage

---

Limitations of the research and safety

Important: there are no solid clinical studies in humans confirming long-term efficacy and safety. The most frequently cited evidence comes from animal experiments and preclinical data.

Possible reported effects:

• redness or pain at the injection site
• Theoretical caution in oncology: stimulating angiogenesis could, in theory, promote the vascularization of tumor tissues.

---

Use and preparation (general information)

In the most common settings, BPC-157 is administered by subcutaneous or intramuscular injection, typically on a daily basis. Protocols vary depending on the objective and context.

Preparation of the solution (reconstitution):

1. Inject the diluent into the vial by running the liquid down the side (not directly onto the powder).

2. Stir gently until completely dissolved (do not shake).

3. The solution must be clear.

Practical note: Do not mix different peptides in the same syringe, as this may compromise the stability of the molecules.

---

Storage

After reconstitution, the solution should be stored in a refrigerator at 2–8°C. Generally, the shelf life is approximately 21 days, and may be extended if bacteriostatic water is used (if specified by the product and context of use).